Four days after joining the proverbial winner’s circle thanks to its bile duct cancer drug candidate, Relay Therapeutics is upping the ante and looking to up its coffers by a few hundred million for its next steps.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,